Duration of dual antiplatelet therapy and outcome in patients with acute coronary syndrome undergoing percutaneous revascularization: A meta-analysis of 11 randomized trials-Reference-Cited by-同舟云学术

Duration of dual antiplatelet therapy and outcome in patients with acute coronary syndrome undergoing percutaneous revascularization: A meta-analysis of 11 randomized trials

Published:2018-08 Issue: Volume:264 Page:30-38
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Verdoia Monica,Khedi Elvin,Ceccon Claudia,Suryapranata Harry,De Luca Giuseppe

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference46 articles.

1. Nine-month results of the REFORM study

2. Prasugrel versus clopidogrel in patients with acute coronary syndromes;Wiviott;N. Engl. J. Med.,2007

3. Ticagrelor versus clopidogrel in patients with acute coronary syndromes;Wallentin;N. Engl. J. Med.,2009

4. Dual antiplatelet therapy for secondary prevention of coronary artery disease;Degrauwe;Open Heart,2017

5. Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial;Mehran;Eur. Heart J.,2009

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of the first Iranian clinical practice guidelines for the diagnosis, treatment, and secondary prevention of acute coronary syndrome;Journal of Research in Medical Sciences;2024-05

2. Predictors of gastrointestinal bleeding in patients with acute coronary syndrome and the optimal duration of dual antiplatelet therapy;Journal of Research in Medical Sciences;2024-03

3. Effect of pretreatment with a P2Y12 inhibitor in patients with non-ST-elevation acute coronary syndrome: a systematic review and network meta-analysis;Frontiers in Cardiovascular Medicine;2023-07-19

4. Duration and clinical outcomes of dual antiplatelet therapy following percutaneous coronary intervention for acute coronary syndrome: A multicentre “real-world practice” registry-based study;Frontiers in Cardiovascular Medicine;2023-04-06

5. Dual Antiplatelet Therapy for 3 or 12 Months in Patients with Non-ST-elevation MI/Unstable Angina or ST-elevation MI: Analysis of the REDUCE Trial;Journal of Asian Pacific Society of Cardiology;2022-07-29